A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases by 源�寃쏀솚 et al.
A haplotype-based molecular analysis of
CFTR mutations associated with respiratory
and pancreatic diseases
Ji Hyun Lee1, Ji Ha Choi1, Wan Namkung1, John W. Hanrahan5, Joon Chang2,
Si Young Song2, Seung Woo Park2, Dong Soo Kim3, Joo-Heon Yoon4, Yousin Suh6,
In-Jin Jang7, Joo Hyun Nam8, Sung Joon Kim8, Mi-Ook Cho9, Jong-Eun Lee10,
Kyung Hwan Kim1 and Min Goo Lee1,*
1Department of Pharmacology and Brain Korea 21 Project for Medical Science, 2Department of Internal Medicine,
3Department of Pediatrics and 4Department of Otorhinolaryngology, Yonsei University College of Medicine,
Seoul 120-752, Korea, 5Department of Physiology, McGill University, Montreal, Quebec Canada, H3G 1Y6,
6Department of Biochemistry and Molecular Biology and 7Department of Pharmacology, Seoul National University
College of Medicine, Seoul 110-799, Korea, 8Department of Physiology, Sungkyunkwan University School of
Medicine, Suwon 440-746, Korea, 9Metagentech Co., 207-10 Poi-Dong, Kangnam-Gu, Seoul 135-963, Korea and
10DNA Link Inc., 15-1 Yonhee-Dong, Seodaemun-Gu, Seoul 120-110, Korea
Received April 21, 2003; Revised June 20, 2003; Accepted July 7, 2003
Aberrant membrane transport caused by mutations in the cystic ﬁbrosis transmembrane conductance
regulator (CFTR) gene is associated with a wide spectrum of respiratory and digestive diseases as well as
cystic ﬁbrosis. Using a gene scanning method, we found 11 polymorphisms and mutations of the CFTR gene
in the Korean population. Individual variants at these sites were analyzed by conventional DNA screening in
117 control and 75 patients having bronchiectasis or chronic pancreatitis. In a haplotype determination based
on a Bayesian algorithm, 15 haplotypes were assembled in the 192 individuals tested. Several haplotypes,
especially with Q1352H, IVS8 T5, and E217G, were found to have disease associations in a case–control
study. Notably, a common polymorphism of M470V appears to affect the intensity of the disease association.
Among the two haplotypes having IVS8 T5, the T5-V470 haplotype showed higher disease association than
the T5-M470 haplotype. In addition, a Q1352H mutation found in a V470 background showed the strongest
disease association. The physiological signiﬁcances of the identiﬁed mutations were rigorously analyzed.
Non-synonymous E217G and Q1352H mutations in the M470 background caused a 60–80% reduction in
CFTR-dependent Cl currents and HCO3
-transport activities. Surprisingly, the additional M470V poly-
morphic variant with the Q1352H mutation completely abolished CFTR-dependent anion transport activities.
These ﬁndings provide the ﬁrst evidence on the importance of CFTR mutations in the Asian population.
Importantly, the results also reveal that interactions between multiple genetic variants in cis affect the ﬁnal
function of the gene products.
INTRODUCTION
Loss of anion transport caused by mutations in the cystic
fibrosis transmembrane conductance regulator (CFTR; MIM
602421) gene is associated with a wide spectrum of respiratory
and pancreatic disorders, as well as classically defined cystic
fibrosis (CF) (1–5). Currently, more than 1000 mutations of
CFTR are registered with the Cystic Fibrosis Gene Analysis
Consortium (CFGAC; www.genet.sickkids.on.ca/). Several
mutations of CFTR, such as F508del, G542X and N1303K,
are associated with severe CF phenotypes and display high
disease penetrance. However, many other mutations are instead
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associated with monosymptomatic diseases of lung, pancreas
or vas deferens, and show partial penetrance. Factors such as
environmental effects can be employed to explain the
heterogeneity of the disease phenotypes caused by mild
mutations (6). An important approach for resolving these
heterogeneous phenotypes is to characterize the haplotype
background of each individual, especially for the intragenic
regions of CFTR. Various interactions or additive effects
between multiple mutations and/or polymorphic sites will code
for the final destined function of the gene products. In addition,
haplotype information is also useful for tracing the disease-
associated gene flow in population history (7–9).
It is expected that, if any functional CFTR gene variations
exist in the population, they are associated with epithelial
disorders, since CFTR performs a critical role in the overall
regulation of epithelial ion transport and there are no
functional analogues or substitutes for this protein (10–14).
Although mutations and polymorphisms of CFTR have been
extensively studied in Western populations, its importance is
less emphasized in East Asia due to the rare presentation of
classical CF. However, other diseases reported to be associated
with CFTR mutations, such as bronchiectasis and chronic
pancreatitis, are also present in the East Asian population.
Isolated pulmonary bronchiectasis has been regarded as a
different clinical entity from CF, though bronchiectasis is a
common feature of CF. However, it was suggested that certain
cases of monosymptomatic bronchiectasis are also associated
with CFTR mutations (2). Similarly, a couple of recent reports
showed that significant proportions of monosymptomatic
chronic pancreatitis patients had CFTR mutations (3,4).
Therefore, we investigated the possibility of an association
between genetic variations of CFTR and these diseases in the
Korean population by using integrated gene analysis in
combination with molecular and functional studies.
Gene scanning and haplotype assembly revealed that the
background haplotype for F508del (8), which accounts for 66%
of worldwide cystic fibrosis, is very rare in the Korean
population. However, several other haplotypes, especially
mutations with decreased membrane expression and reduced
HCO3
 transport, were found to be associated with respiratory
or pancreatic diseases. Notably, an additional polymorphic
variation of M470V affects the intensity of disease association
and the anion transport function of CFTR protein. The present
study is the first comprehensive report demonstrating the
significance of CFTR variants in association with chronic
respiratory and pancreatic diseases in East Asians. Moreover,
the results also reveal that interaction between multiple genetic
variants in cis affect the function of CFTR gene products.
RESULTS
Genetic variants of CFTR in the Korean population
The genetic variants of CFTR have not been thoroughly
investigated in East Asians due to the rare incidence of classical
CF. Therefore, initially we undertook to find the common
CFTR mutations and polymorphisms in the Korean population.
We used the two-dimensional gene scanning (TDGS) technique
to efficiently scan entire CFTR exons. Although a TDGS trial
for the exploration of human CFTR has been described
previously (15), a whole set of primers were newly designed for
the optimal PCR amplification, denaturing gradient gel
electrophoresis (DGGE) separation, and DNA-fragment dis-
tribution in two-dimensional gel (Supplement). The resulting
test permitted the detection of mutations and polymorphisms in
CFTR coding regions as well as splice site mutations.
TDGS was performed on a total of 100 samples from 28
healthy controls, 47 bronchiectasis patients, and 25 chronic
pancreatitis patients. Typical TDGS patterns are shown in
Figure 1. In samples from healthy control subjects, two
heteroduplex bands were frequently seen in exons 10 and 14a,
and identified as M470V and 2694T/G (T854), respectively. In
samples from patients, several other heteroduplexes were found
including one in exon 22, which was identified as Q1352H
(G to C change at nucleotide 4188). After comprehensive gene
scanning and subsequent nucleotide sequencing, we found nine
diallelic variations in 50-UTR and in several exons (Table 1, left
column). Among them, two were novel mutations and the other
seven had been previously registered in CFGAC.
Genotype frequencies in control and patient groups
To investigate the pathological association between CFTR
genetic variations and bronchiectasis or chronic pancreatitis, a
case–control study was performed using samples from 192
subjects as detailed in Materials and Methods. In addition to
the nine variations found by TDGS, we included the 10 most
common worldwide disease-causing mutations (data obtained
from CFGAC) and a possible disease-associated microsatellite,
IVS8 Tn (Table 1). Diallelic loci were analyzed by an
automated DNA screening (SNaPshot; Applied Biosystems
Inc.), and the Tn numbers were identified by bi-directional
nucleotide sequencing. Among the 10 worldwide disease-
causing mutations, only one case of R117H was found in a
control subject. The genotype frequencies found at each locus
are listed in Table 2.
Genetic variants at several sites were found to be associated
with bronchiectasis and/or chronic pancreatitis, the most
notable being Q1352H. The heterozygote frequency of
Q1352H was significantly higher in bronchiectasis (P¼ 0.02)
and chronic pancreatitis patients (P¼ 0.005) than in the control
group. The frequency of E217G also seemed to be higher in
bronchiectasis patients, especially in the subgroup of child
bronchiectasis (P¼ 0.04; ages under 18, three cases in 20
patients), although it was not significant when all patients were
included (P¼ 0.10; four cases in 47 patients). It has been
suggested that IVS8 T5 is associated with CF or monosympto-
matic CF-related diseases by affecting RNA splicing (16). The
present data also showed the increased frequency of IVS8 T5 in
the patient groups, especially in those with bronchiectasis
(P¼ 0.03). Since a total of 22 comparisons were made on 11
loci, their overall significances were evaluated using the
information from all loci examined by two different
approaches, the Bonferroni technique and the summation of
chi-square statistics (17). When applying the conservative
Bonferroni technique, no individual P-values in Table 2 were
smaller than the Bonferroni significance (0.0023; a/number of
comparison¼ 0.05/22). However, the summed chi-square
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strongly suggested differences among individual groups
(P¼ 0.00015; w2¼ 54.1, degree of freedom¼ 22). Therefore,
the present data set is a typical example that the two different
approaches for multiple comparisons do not agree (17).
Haplotype patterns and their disease associations
Since multiple alleles exist in both controls and patients, a
haplotype-based approach was used to provide a better
understanding of the disease-associated CFTR variations.
Haplotypes were assembled using the genotype data obtained
from the 192 tested samples and the Haplotyper program based
on the Bayesian algorithm (7). Eleven loci consisting of 10
diallelic variants and a microsatellite of IVS8 Tn were analyzed.
Since the program accepts only diallelic data, in the case of
IVS8 Tn, T5 was considered as mutant and all other alleles were
inputted as wild-type (WT). Although a true haplotype can be
resolved by experimental molecular methods, it is not practical
for large-scale haplotype determinations. Since it has been
shown that the average error rate of the Bayesian method is less
than 0.01 for samples of 100 individuals with 20 loci
Figure 1. Two-dimensional gene scanning (TDGS) of human CFTR. The entire CFTR coding regions and parts of the introns were amplified by two-step PCR, as
described in Materials and Methods. Forty-one short PCR fragments were distributed in two-dimensional gels according to their molecular weights and melting
temperatures (DGGE). (A) A sample from a control subject shows heteroduplex bands in exons 10 and 14a. (B) A sample from a pancreatitis patient shows hetero-
duplex bands in exons 14a and 22. (C) The genetic variation in exon 22 was identified as Q1352H (4188G>C) by bi-directional nucleotide sequencing.
Table 1. CFTR genetic variants analyzed in this study
Variations found
by TDGS
Most common worldwide
disease-causing mutations
Reported
disease-associated
microsatellite
8G/C (50UTR)a R117H (exon 4) T5-7,9 (IVS 8) (16)
I125T (exon 4)b 621 þ 1G>T (intron 4)
E217G (exon 6a)b F508del (exon 10)
1059C>T
(exon 7, A309)a
1717-1G>A
(intron 10)
M470V (exon 10)b G542X (exon 11)
I556V (exon 11)b G551D (exon 11)
2694T/G
(exon 14a, T854)b
R553X (exon 11)
Q1352H (exon 22)b R1162X (exon 19)
R1453W (exon 24)b W1282X (exon 20)
N1303K (exon 21)
Mutation names and nucleotide numbers are presented according to the Cystic
Fibrosis Genetic Analysis Consortium (CFGAC; www.genet.sickkids.on.ca/).
aNew genetic variations found in this study.
bRegistered variations in CFGAC.
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(partition–ligation algorithm in 7) and we used a larger popu-
lation (192 individuals) with fewer gene variations (11 sites),
the error rate is expected to be far less than 0.01 in the present
haplotype determination.
After 100 rounds of iterations, 15 haplotypes were assembled
and their identification (ID) numbers were assigned according to
the total sample frequencies (Table 3). In the initial step, we
classified each haplotype using two common polymorphisms of
M470V and 2694T/G (Table 3, right-most column). One
interesting observation was of a tight association between the
M470V and the 2694T/G (T854) loci. With the exception of
haplotypes 8 (2–2), 12 (1–1), and 13 (2–2), all other haplotypes,
that is 97% of the control population, were in the background of
either V470-2694T (2–1) or M470-2694G (1–2). Therefore,
haplotypes 4, 5, 7, 11 and 14 seem to be the variants of haplo-
type 1, and haplotypes 3, 6, 9, 10 and 15 be the variants of
haplotype 2. It was found that haplotype 12 has IVS8 T9 by a
different set of haplotype assembly using T9 as mutant instead of
T5. Therefore, haplotype 12 was found to have IVS8 T9-M470-
2694T, and it has been reported that 95% of F508del mutants
arise from this haplotype (8). Notably, the allele frequency of
haplotype 12 in the control Korean population (0.9%) was much
less than that in the Caucasian population (7.3%).
Although the frequency of haplotype 1, which has V470,
was highest in the Korean population, we used haplotype 2,
which has M470, as a standard haplotype for statistical
analysis since the sequence of haplotype 2 matches with the
registered CFTR sequences in most databases. In addition,
it was reported that V470 CFTR has about a half of the
M470 CFTR function, when whole cell Cl channel activities
were compared (16). Haplotypes showing extremely low
frequencies (<2%) in all groups (haplotypes 8–15) were
excluded from the statistical analysis. Similar to the genotype
data (Table 2), none of the comparisons in haplotype data
(Table 3) reached the Bonferroni significance (0.004; a/number
of comparison¼ 0.05/12). However, the overall chi-square
value again suggested a frequency difference between the
control and the patient groups (P¼ 0.014; w2¼ 26.2, degree of
freedom¼ 12).
As expected from the genotype data, haplotype 4 containing
Q1352H showed the strongest association with bronchiectasis
and chronic pancreatitis in the Korean population (P¼ 0.02 and
P¼ 0.008, respectively). The frequency of haplotype 6
containing E217G was 5.8-fold higher in child bronchiectasis
patients (7.5%, three in 40; P¼ 0.03) than that in the control
population (1.3%, three in 234), although this was not
significant for all bronchiectasis patients (4.3%, four in 94;
P¼ 0.08). The genotype data showed a possible association
between IVS8 T5 and bronchiectasis (Table 2). In the haplotype
assembly of Table 3, haplotypes 5 and 9 were found to have
IVS8 T5. The frequencies of haplotypes 5 and 9 were similar in
control populations. Interestingly, the frequency of haplotype 5
containing another variation of V470 was significantly
increased in bronchiectasis group (P¼ 0.02), while that of
haplotype 9 containing M470 was not changed.
Molecular and functional studies on single mutants
A molecular and functional study of the CFTR mutations was
performed to draw concrete conclusions on the disease
associations and to identify the underlying mechanisms of
defective CFTR function. Among the non-synonymous muta-
tions identified in the Korean population, four were selected for
functional study based on the results from the present study and
from information reported to the CFGAC (Table 4). To isolate
each mutation-induced effect, all mutations were introduced
into the same haplotype 2 background, which contains M470.
Many disease-causing CFTR mutations produce folding or
maturation defects (18,19). Therefore, we initially studied the
protein expression levels of each mutant. WTand mutant pNUT-
CFTR clones were transfected to CHO-K1 cells and stable
transfectants were selected using methotrexate. After lysing the
cells, proteins were harvested and blotted with antibodies against
CFTR. Similar to that found by previous reports, complex-
glycosylated ‘band C’ proteins were principally detected in the
CHO cell systems rather than the primary-translated ‘band A’ or
the core-glycosylated ‘band B’ forms (16). As shown in Figure
2A, the protein expressions of mature glycosylated CFTR were
significantly decreased in E217G and Q1352H mutations.
Similar expression levels of dihydrofolate reductase (DHFR), a
cis-gene product in the expression vector, in each transfectant
Table 2. Frequency of CFTR gene variants in the Korean population
Variation Genotype Group (number)
Healthy control
(n¼ 117)
Bronchiectasis
(n¼ 47)
Pancreatitis
(n¼ 28)
Diallelic
-8G/C þ/þ 105 44 22
þ/a 12 3 6
R117H þ/þ 116 47 28
þ/ 1 0 0
I125T þ/þ 116 46 27
þ/ 1 1 1
E217G þ/þ 114 43 27
þ/ 3 4b 1
1059C>T þ/þ 117 47 27
(A309) þ/ 0 0 1
M470V þ/þ 23 3 6
þ/ 52 28 14
/ 42 16 8
I556V þ/þ 111 45 28
þ/ 6 2 0
2694T/G þ/þ 41 16 8
(T854) þ/ 51 27 14
/ 25 4 6
Q1352H þ/þ 116 43 24
þ/ 1 4* 4**
R1453W þ/þ 115 46 28
þ/ 2 1 0
Microsatellite
T5-7,9 5/7 4 6* 2
(IVS 8) 6/7 0 1 0
7/7 110 39*c 26
7/9 3 1 0
Differences between control and disease groups were analyzed by a chi-square
test. When an expected cell value was less than 5, Fisher’s exact test was used.
Significant increases in the disease cases are presented in bold.
aMinus signs () indicate the variant type of diallelic variations.
bP¼ 0.04, in the case of child bronchiectasis (ages under 18, 3 cases in 20
patients).
cDecreased frequency in the disease cases. *P< 0.05, **P< 0.01 difference
from control.
2324 Human Molecular Genetics, 2003, Vol. 12, No. 18
 at Y
O
N
SEI U
N
IV
ERSITY
 M
ED
ICA
L LIBRA
RY
 on July 15, 2014
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
Table 3. Haplotype assembly
Allele
ID
-8G/C R117H I125T E217G 1059C/T T5-7,9 M470V I556V 2694T/G Q1352H R1453W Group
aM470V-2694T/G
background
Control,
n (%)
Bronchiectasis,
n (%)
Pancreatitis,
n (%)
1 G R I E C WTb V I T Q R 121 (51.7) 47 (50.0) 24 (42.9) 2–1
2 G R I E C WT M I G Q R 78 (33.3) 25 (26.6) 18 (32.1) 1–2
3 C R I E C WT M I G Q R 11 (4.7) 3 (3.2) 5 (8.9) 1–2
4 G R I E C WT V I T H R 1 (0.4) 4 (4.3)* 4 (7.1)** 2–1
5 G R I E C 5 V I T Q R 2 (0.9) 5 (5.4)* 1 (1.8) 2–1
6 G R I G C WT M I G Q R 3 (1.3) 4 (4.3)c 1 (1.8) 1–2
7 G R I E C WT V V T Q R 5 (2.1) 2 (2.2) 0 (0.0) 2–1
8 G R I E C WT V I G Q R 4 (1.7) 1 (1.0) 0 (0.0) 2–2
9 G R I E C 5 M I G Q R 2 (0.9) 1 (1.0) 1 (1.8) 1–2
10 G R I E C WT M I G Q W 2 (0.9) 1 (1.0) 0 (0.0) 1–2
11 G R T E C WT V I T Q R 1 (0.4) 1 (1.0) 1 (1.8) 2–1
12 G R I E C WT M I T Q R 2 (0.9) 0 (0.0) 0 (0.0) 1–1
13 C R I E C WT V I G Q R 1 (0.4) 0 (0.0) 0 (0.0) 2–2
14 G H I E C WT V V T Q R 1 (0.4) 0 (0.0) 0 (0.0) 2–1
15 C R I E T WT M I G Q R 0 (0.0) 0 (0.0) 1 (1.8) 1–2
Total 234 (100.0) 94 (100.0) 56 (100.0)
Haplotypes were assembled using a software based on the Bayesian algorithm (Haplotyper) (7). Allele identification numbers were assigned according to the total frequency of haploid genes analyzed in this
study. Differences between control and disease groups were analyzed by the chi-square test or Fisher’s exact test (expected cell value <5) using the frequency of haplotype 2 as standard.
aM470V-2694T/G background was analyzed to classify each haplotype.
bT6, T7 and T9 were regarded as wild-type.
cP¼ 0.03, in the case of child bronchiectasis (ages under 18, 10 cases of haplotype 2 and 3 cases of haplotype 6 in 40 haploid genes). *P< 0.05, **P< 0.01 difference from control.
H
u
m
a
n
M
o
lecu
la
r
G
en
etics,
2
0
0
3
,
V
o
l.
1
2
,
N
o
.
1
8
2
3
2
5
 at YONSEI UNIVERSITY MEDICAL LIBRARY on July 15, 2014 http://hmg.oxfordjournals.org/ Downloaded from 
verified that the results were not due to a lower transfection
efficiency. Compared with WT, the expression levels of E217G
and Q1352H were reduced by 64 and 73%, respectively, when
CFTR band intensities were normalized against those of the
cis-gene product DHFR (Fig. 2B).
CFTR protein has a Cl channel function (20,21). Thus, the
chloride channel activities of WT and mutant CFTR were
measured in both whole-cell and single-channel configurations.
In the whole cell current measurements, cAMP cocktail (5 mM
forskolin plus 100 mM IBMX) treatment produced a large
current in the NMDG-Cl solutions with linear I-V relationships
(Fig. 3A and B). Treatment of glibenclamide (100 mM) or N-
phenylanthranilic acid (DPC, 100 mM) inhibited this current by
76 4 and 89 5%, respectively (not shown). These char-
acteristics were in line with the previous observations on CFTR
Cl currents (11). Interestingly, all the mutants showed lower
current densities (pA/pF) than WT CFTR. Among them,
Q1352H showed the largest decrease (by 71%) and R1453W
showed the smallest decrease (by 37%) in whole cell Cl
currents (Fig. 3C).
Single channel kinetics were analyzed in cell-attached
configurations, since the protein expression levels (Fig. 2) did
not perfectly match with the whole cell Cl currents (Fig. 3C).
No spontaneous channel activity was observed prior to the
addition of cAMP cocktail. When the cells were stimulated
with cAMP cocktail, low conductance currents were induced.
Current records of 6min duration at 80mV (Fig. 3D) were
analyzed for open probability (Po) and the results obtained
were summarized as a bar graph (Fig. 3F). Compared with WT,
Po was significantly reduced in I556V (by 34%), Q1352H (by
55%), and R1453W (by 78%). To determine the size of a single
channel conductance, all point histograms were made at each
voltage from 120 to þ120mV (in increments of 40mV) and
fitted to a Gaussian distribution. An example at þ80mV is
shown in Figure 3E. The average conductance of WT CFTR
was 7.6 pS and no significant changes were observed in the
mutant CFTRs. Therefore, it was concluded that the decreased
current density in the whole cell Cl current of E217G (Fig. 3C)
was due to the decreased membrane expression, and those of
I556V and R1453W were due to the decreased Po. In the case
of Q1352H, both membrane expression and Po were decreased.
Recently, it was found that CFTR plays an important role in
transepithelial HCO3
 transport by regulating Cl/HCO3

exchange (11–14). Reduced HCO3
 secretion by defective
CFTR-dependent HCO3
 transport has been suggested to be an
important pathologic mechanism in mutant CFTR-induced
respiratory and pancreatic diseases (22,23). Therefore, Cl/
HCO3
 exchange activities were measured in WT and mutant
CFTR transfected cells by estimating pHi increase due to Cl

removal from the HCO3
-buffered perfusate (Fig. 4). In mock
transfected cells, basal Cl/HCO3
 exchange activity was
0.083 0.05 DpH unit/min and this was not significantly
changed by forskolin treatment. However, in the WT-CFTR
transfected cells, basal activity was increased to 0.141 0.021
and forskolin treatment highly stimulated Cl/HCO3

exchange to 0.677 0.063 (Fig. 4A). To isolate CFTR-
dependent Cl/HCO3
 exchange, cAMP-activated changes
were calculated and analyzed in each mutant (Fig. 4B).
Compared to the WT, E217G and Q1352H showed significant
reductions in forskolin-stimulated Cl/HCO3
 exchange by 65
and 77%, respectively.
Effects of M470V on Q1352H
The Q1352H mutation showed the highest disease associations
in the genotype data. Since Q1352H is appeared only in the
V470 background in the tested population (Table 3), we made
M470V changes in WT- and Q1352H-CFTR clones and
performed functional studies. As shown in Figure 5A,
additional M470V change did not alter the protein expression
levels in either WT- or Q1352H-CFTR. However, additional
M470V change in Q1352H abolished cAMP-activated Cl
currents (Fig. 5C and D) and cAMP-activated Cl/HCO3

exchanges (Fig. 5E and F) by 99 and 95%, respectively.
DISCUSSION
The present study is the first comprehensive report on disease-
associated CFTR gene variations in the East Asian population.
CFTR mutation/polymorphism patterns in the Korean popula-
tion were found to be quite different from those observed in the
Caucasian populations. Among the 10 common worldwide
disease-causing mutations, only one case of R117H was found
Figure 2. Protein expression in WT and mutant CFTR. (A) CHO-K1 cells sta-
bly expressing WT or mutant CFTR were lysed, proteins were harvested and
blotted with monoclonal antibodies against NBD2 of CFTR and a cis-transfec-
tion marker DHFR. (B) Staining intensities of CFTR and DHFR bands were
analyzed and the intensity ratios of CFTR/DHFR were compared. Results from
four separate experiments were summarized.
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in a control subject. One of the interesting observations was the
rare frequency of haplotype 12 in the Korean population
(0.9%). This haplotype has IVS8 T9-M470-2694T and it
corresponds to haplotype IIIa of Cuppens’ report (8). The
frequency of this haplotype is 7.3% in the normal Belgian
population. However, over 95% of the three most common CF-
causing mutations, F508del, G542X and N1303K, arise from
this haplotype. For some reason, the gene flow or selection
pressure for this haplotype has been extremely low in the
Korean population. Thus, we postulate that the low frequency
of haplotype 12 is the principal reason for the rare incidence of
classical CF in East Asia.
It is known that polymorphisms in IVS8 Tn affect the RNA
splicing of exon 9, and that the IVS8 T5 variation reduces splice
Figure 3. Cl channel activities of WT and mutant CFTR. (A–C) Cl currents were measured in the whole cell configuration. After establishing the whole cell
configuration with NMDG-Cl rich solutions, CFTR was activated using a cAMP cocktail, 5mM forskolin and 100mM IBMX. Currents were recorded at a holding
potential of 30mV (A) and peak currents were normalized as current densities (pA/pF) (C). The I–V relationships were obtained using a ramp pulse from
50mV to þ50mV at peak current (B). (D–F) Single-channel recordings were performed in the cell-attached configuration with cAMP cocktail stimulation.
Current records at 80mV (D) were analyzed to estimate the open probability (Po) (F). Unitary conductance was calculated using all point histograms constructed
for voltages ranging from 120 to þ120mV at 40mV intervals. An example at þ80mV is shown in (E). (C) and (F) summarize the results from eight to 10
experiments for each mutant. *P< 0.05, **P< 0.01 difference from WT.
Table 4. Characteristics of CFTR mutants selected for functional studies
Name Nucleotide change Exon Domain Evolutionary
conservationa
Possible disease associationb
E217G 782A>G 6a EC2 b, h, r CF with pancreatic sufficiency (Polish), Panbronchiolitis (Japanese)
I556V 1798A>G 11 NBD1 All seven species Chronic bronchitis (French)
Q1352H 4188G>C 22 NBD2 All seven species CBAVD (Japanese), Panbronchiolitis (Japanese)
R1453W 4489C>T 24 IC10 b, h, m, r, s Panbronchiolitis (Japanese)
aEvolutionary conservations are compared in CFTR genes of bovine (b), dogfish (d), human (h), mouse (m), rabbit (r), sheep (s), and xenopus (x).
bNotes reported to CFGAC. CBAVD, congenital bilateral absence of vas deferens; CF, cystic fibrosis; EC, extracellular domain; IC, intracellular domain; NBD,
nucleotide binding domain.
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acceptor efficiency. Hence, this variation reduces proper RNA
and protein synthesis and seems to be associated with CF and/or
CF-related diseases, such as congenital bilateral absence of vas
deferens (CBAVD). In addition, it was suggested that when
IVS8 T5 is combined with additional activity-reducing varia-
tions, such as the higher number of IVS8 (TG)m and the V470
variant, it shows higher disease penetrance (16). Although
(TG)m was not analyzed in this study, the results of the M470V
polymorphism support this notion. Of the two IVS8 T5
containing haplotypes (haplotypes 5 and 9), only haplotype 5,
which also has the low activity variation of V470, showed an
association with the disease phenotype (Table 3). Interestingly,
a case of T6 was found in a bronchiectasis patient in addition to
the well-known T5, T7 and T9 alleles. However, its disease
association is uncertain at this moment, and future functional
transcript studies are required to assess its clinical relevance.
Q1352H was found to be the most notable mutation in both
case–control and molecular functional studies. It is located in a
conserved glutamine-rich sequence, called the ‘linker peptide’,
‘signature motif ’ or ‘motif C’ in the second nucleotide binding
domain (NBD2) of CFTR. In a structural study of the NBD
domain of a bacterial ABC transporter, it was suggested that
the linker peptide would be an essential motif for the integrity
of folded NBD structures and for the regulation of ATP
hydrolysis (24). Our observations are wholly in accord with this
suggestion. The linker region of CFTR NBD2 is composed of
‘LSHGHKQ’ and differs slightly from the classic linker
sequence of ‘LSGGQ’. However, its sequence is highly
conserved in all vertebrates and the change of the last
glutamine into histidine (Q1352H) evoked defects in protein
Figure 4. Measurements of CFTR-dependent Cl/HCO3
 exchange.
Coverslip-grown CHO cells were loaded with BCECF and pHi was measured
in a perifusion chamber. Cl/HCO3
 exchange activities were estimated from
the initial rate of pHi increase after Cl

0 removal in the HCO3
 buffered per-
fusate (25mM HCO3
 with 5% CO2). After determining the basal activity,
the forskolin-stimulated (5 mM) activities were measured. Representative traces
of Mock-, WT- and Q1352H-transfected cells are shown in (A), and the results
of five to six experiments for each mutant are summarized in (B). **P< 0.01
difference from WT.
Figure 5. Effects of M470V on Q1352H mutant. M470V variation was intro-
duced in the WTand the Q1352H clones and protein expressions and functional
activities were measured using the protocols described in the legends of Figures
2–4. M470V change did not alter the protein expression levels in WT- or
Q1352H-CFTR (A, B). However, additional M470V change in Q1352H abol-
ished cAMP-activated Cl currents (C, D) and Cl/HCO3
 exchanges (E, F).
*P< 0.05, **P< 0.01 difference from WT.
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expression and affected the gating properties of single channel
kinetics (Figs 2 and 3).
E217G was previously identified in a Polish CF patient with
pancreatic sufficiency (data from CFGAC) and showed a
marginal disease association in the present case–control study.
These results imply that E217G is a mild mutation, which is
also supported by our molecular data. The E217G mutation
partially decreased membrane protein expression and anion
transporting activities by 60–70%. However, the strongly
disease associated Q1352H mutation also decreased the protein
expression and functional activities by only 70–80%, which
was not much different from E217G when they were measured
in the same haplotype background of M470 (Figs 2–4). Of
interest, E217G was found to arise in the haplotype having a
high activity type of M470 (haplotype 6), and Q1352H to arise
in the low activity type of V470 (haplotype 4) in the real
population. Therefore, combinatorial effects with M470V locus
may influence the overall function of haploid gene products in
Q1352H mutation. Indeed, molecular data of double mutagen-
esis showed a surprising result that the additional change of
M470V in Q1352H abolished the anion transporting activities
of CFTR protein (Fig. 5). The reasons for the complete
reduction of functional activities are unclear at this moment.
A plausible scenario is that M470V and Q1352H might
be involved in the cross talk and/or interaction between the
two NBDs of CFTR (25,26), since M470V and Q1352H are
located in the NBD1 and NBD2, respectively. Although it
was previously suggested that V470 may affect CFTR
function (5,16), this is the first report directly showing that
cis-interaction of V470 determines the disease status of
a mutant CFTR gene. The above results suggest that multiple
genetic variations in CFTR gene can affect the overall function
of the protein and the intensity of the disease association.
In this regard, haplotype-based approaches should be
emphasized and encouraged to evaluate the disease
associations not only of CFTR genes, but also of candidate
genes in other diseases.
In the case–control analysis, overall statistical significances
were analyzed by the Bonferroni technique and the summation
of chi-square method. However, the two methods showed
contradictory results. These phenomena are frequently con-
fronted in the genetic association studies for multiple loci
analysis (17), and it is still the subject of debate as to what kind
of statistical test will be ideal to assess the clinical study with
multiple measures (27,28). If the conservative Bonferroni
technique is adopted, positive findings are hardly observed in
most studies and the risk of false negative (type II error) is
increased, especially for mutations with rare incidences. In
contrast, if we simply accept P< 0.05 at single locus analysis,
the risk of false positive (type I error) will be increased.
Therefore, it was once suggested that the summation of chi-
square statistics followed by an analysis of individual loci
would be the most appropriate approach (17). However, others
do not completely agree with this type of approach and suggest
other statistical methods (27,28). In the present study, to
minimize the possible errors, we employed the integrated
approach that identifies the possible disease-associated varia-
tions from the population data using conventional statistics and
then verifies the functions of their gene products at the
molecular level. We believe this method is a very effective
approach to assess the clinical relevance of gene variations and
to overcome the statistical limitations.
In conclusion, CFTR mutations of M470V-Q1352H, IVS8
T5-M470V, and E217G are associated with bronchiectasis and
chronic pancreatitis. In the enrolled Korean population, 20%
of patients with bronchiectasis and chronic pancreatitis of an
unknown etiology possessed CFTR haploid genes bearing the
above mutations. Defects in CFTR-dependent ion transport are
an important aggravating factor in the disease development
and/or progression in addition to other genetic and environ-
mental factors.
MATERIALS AND METHODS
Studied samples
This study was approved by the institutional review board of
Yonsei Medical Center, Seoul, Korea. A series of 75 unrelated
Korean patients having disseminated bronchiectasis or chronic
pancreatitis of unknown origin were enrolled after giving
informed consent. The bronchiectasis group was composed of
20 pediatric patients (ages 1–18) and 27 adult patients (ages
22–74), and the diagnosis of disseminated bronchiectasis was
confirmed by high-resolution computer tomography. Among
the adult bronchiectasis patients, 15 patients had a history of
childhood onset and 10 patients had accompanying asthma
symptoms. All the enrolled bronchiectasis patients did not have
the symptoms and signs related to classical CF, such as pre-
dominant upper lobe involvement, malabsorption and intestinal
obstruction. The 28 chronic pancreatitis patients were diag-
nosed based on standard criteria, which included abnormalities
on histologic analysis of biopsy specimens, visible calculi on
radiologic examinations, or unequivocally abnormal findings
by endoscopic pancreaticography in addition to their compa-
tible clinical presentations. Alcoholic subjects taking over 40 g
of ethanol daily were excluded from the study. One-hundred
and seventeen healthy control subjects were randomly selected,
and their health statuses were evaluated by routine physical
examinations, laboratory tests and radiologic examinations.
Blood samples were collected from each subject and DNAwas
extracted using a purification kit (Qiagen).
Genetic analysis
The mutation/polymorphism pattern of the CFTR gene in the
Korean population was scanned using the two-dimensional gene
scanning (TDGS) method. PCR primer sets for the human
CFTR gene designed for TDGS analysis were purchased from
Accelerated Genomics Inc. (San Antonio, TX, USA) and the
individual primer sequences without GC clamps are listed in the
Supplementary Material. To increase the efficiency of TDGS,
primers were fluorescently labeled with HEX and GC-clamps
were attached to one primer of each pair (29). The entire CFTR
coding regions and flanking intronic sequences were amplified
by a two-step multiplex PCR reaction. First, a 9-plex long
distance PCR was performed to amplify nine large fragments
encompassing the coding regions of CFTR. These products then
served as templates for four multiplex short PCR reactions to
amplify all 41 target fragments between 100 and 500 bp long.
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Subsequently, PCR fragments were subjected to one round of
complete denaturation and renaturation to create heteroduplex
molecules. The mixture of all CFTR fragments was loaded onto
an automated two-dimensional gel electrophoresis instrument
(OptiAnalyzer 8008HT; Accelerated Genomics), and separated
simultaneously in a DGGE gel according to their fragment size
and melting temperature. The entire DNA fragments were
visualized by a fluorescent scanner (Molecular Imager FX, Bio-
Rad) and heterozygous polymorphisms or mutations were
detected as four spots rather than one spot, representing the two
homoduplex and the two heteroduplex variants. The nature and
location of sequence variations were identified by DNA
nucleotide sequence analysis (Fig. 1).
Genotype characterization of the diallelic loci was performed
by the SNaPshot method (Applied Biosystems, Foster City, CA,
USA) according to the protocol supplied by the manufacturer
on an automated genetic analyzer (Model 3700, Applied
Biosystems) and polymorphisms in the IVS8 Tn microsatellite
were analyzed by bi-directional nucleotide sequencing.
Haplotype assembly was performed using the Haplotyper
program based on the Bayesian algorithm to reconstruct
individual haplotypes from population genotype data (7).
Data on the 10 diallelic variations, which actually exist in the
Korean population, and polymorphisms in IVS8 Tn were used
to generate haplotypes (Table 3). Output consisted of two
parts, individual haplotype information and haplotype pool
information.
Site-directed mutagenesis and expression of CFTR
The use of pNUT-CFTR plasmid for the stable expression of
human wild-type CFTR in mammalian cells has been described
previously (30). The plasmid also contains the gene for
dihydrofolate reductase (DHFR), which enables the selection of
transfectants with methotrexate. Site-directed mutagenesis at
four non-synonymous mutations (Table 4) and M470V was
performed using the QuickChange mutagenesis kit from
Stratagene (La Jolla, CA, USA). The plasmids for WT and
mutant CFTR expression were transfected into a DHFR-
negative CHO-K1 cell line (KCLB 10061; Korea Cell Line
Bank, Seoul, Korea) using LipofectAMINE Plus reagent (Life
Technologies). CHO-K1 cells were maintained in RPMI1640
medium supplemented with 10% fetal calf serum and penicillin
(50 units/ml)/streptomycin (50 mg/ml). Two days after transfec-
tion, methotrexate (500 mg/ml, Alexis) was added to the culture
medium for the selection of transfected cells. For each mutant,
two or three separate stable cell lines were developed using
different batches of clones to confirm similar mutation-induced
functional changes. The mutagenic primers were as follows:
E217G, 50-CTC CTC ATG GGG CTA ATC TGG GGG TTG
TTA CAG GCG TCT G-30 M470V, 50-CTG GAG CAG GCA
AGA CTT CAC TTC TAA TGG TGA TTA TGG GAG-30;
I556V, 50-AGT GGA GGT CAA CGA GCA AGA GTT TCT
TTA GCA AGG TGA AT-30; Q1352H, 50-CCT AAG CCA
TGG CCA CAA GCA CTT GAT GTG CTT GGC TAG-30;
R1453W, 50-GTG AAG CTC TTT CCC CAC TGG AAC TCA
AGC AAG TGC AAG TCT-30.
Immunoblotting of CFTR and DHFR
CHO-K1 cells transfected with pNUT-CFTR vector were
trypsinized, and lysed with a standard lysis buffer containing
protease inhibitor cocktails. Fifty micrograms of protein
samples from WT or mutant CFTR-expressing cells were
suspended in SDS sample buffer and separated by SDS–PAGE
on 6% gels. The separated proteins were transferred to a
nitrocellulose membrane and probed with the monoclonal
antibody M3A7 against the NBD2 domain of CFTR (Upstate
Biotech). After treating with appropriate secondary antibody,
protein bands were visualized using an enhanced chemilumi-
nescence kit (Amersham Pharmacia). To normalize the trans-
fection levels of the pNUT-CFTR plasmids, the expression
levels of a cis-gene product DHFR were analyzed by immuno-
blotting with smaller amount of lysate (10 mg protein) and anti-
DHFR antibodies (Research Diagnostics Inc.). Staining
intensities of CFTR and DHFR bands were analyzed using
an imaging software (MCID version 3.0; Brook University,
St Catharines, Ontario, Canada) and the intensity ratios
of CFTR/DHFR were compared in each mutant transfected
cells.
Measurement of Cl channel activities
Initially, whole-cell recordings were performed on transfected
CHO-K1 cells. The pipette solution contained (in mM)
140 N-methyl D-glucamine chloride (NMDG-Cl), 5 EGTA,
1 MgCl2, 1 Tris–ATP and 10 HEPES (pH 7.2), and the
bath solution contained (in mM) 140 NMDG-Cl, 1 CaCl2,
1 MgCl2, 10 glucose and 10 HEPES (pH 7.4). All experiments
were performed at room temperature (22–25C). Pipettes
were pulled from borosilicate glass and had resistances
of 3–5MO after fire polishing. Seal resistances were
typically between 3 and 10GO. After establishing the
whole-cell configuration, CFTR was activated by adding
5 mM forskolin and 100 mM 3-isobutyl-1-methylxanthine
(IBMX). The holding potential used in the capacitance
experiments was 30mV and the patch-clamp output
was filtered at 5 kHz. Currents were digitized and analyzed
using an AxoScope 8.1 system and a Digidata 1322A AC/DC
converter. Mean currents were normalized as current densities
(pA/pF).
Single channel characteristics of WT and mutant CFTR were
analyzed in the cell-attached configuration using fire-polished
pipettes with a resistance of 10–17MO. The pipette solution
contained (in mM) 140 NMDG-Cl, 1.3 CaCl2, 1 MgCl2, 5
glucose and 10 HEPES (pH 7.4), and the KCl bath solution
contained 140 KCl, 1.3 CaCl2, 1 MgCl2, 5 glucose and 10
HEPES (pH 7.4). Recordings were performed at room
temperature using an Axopatch-200B (Axon Instruments).
The voltage and current data were low-pass filtered at 1 kHz
and stored for later analysis. Single channel data were digitally
filtered at 25Hz, and analyzed using Fetchan and pSTAT v6.0
softwares (Axon Instruments).
Measurement of Cl/HCO3
exchange
Cl/HCO3
 exchange activity was measured by recording the
intracellular pH (pHi) in response to [Cl
]o changes of the
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perfusate, as previously detailed (11). In brief, cell-attached
glass coverslips were washed once with HEPES-buffered
solution A and assembled to form the bottom of a perfusion
chamber. The HEPES-buffered solution A contained (in mM)
140 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 glucose and 10
HEPES (pH 7.4). Cells were loaded with a fluorescent pH
probe BCECF by incubating for 10min at room temperature in
solution A containing 2.5 mM BCECF-AM. After dye loading,
the cells were perfused with a HCO3
-buffered solution and
BCECF fluorescence was recorded at the excitation wave-
lengths of 490 and 440 nm at a resolution of 2/s using a
recording setup (Delta Ram; PTI Inc.). The HCO3
-buffered
solution contained (in mM) 120 NaCl, 5 KCl, 1 MgCl2, 1
CaCl2, 10 glucose, 5 HEPES, 25 NaHCO3 (pH 7.4) and was
continuously gassed with 95% O2 and 5% CO2. Cl
-free
solutions were prepared by replacing the Cl with gluconate.
The 490/440 ratios were calibrated intracellularly by
perfusing the cells with solutions containing 145mM KCl,
10mM HEPES, and 5 mM nigericin with the pH adjusted to
6.2–7.6.
Statistical analysis
To analyze genotype and haplotype data (Tables 2 and 3),
differences between control and disease groups were compared
by a chi-square test. When an expected cell value was less
than 5, Fisher’s exact test was used. Two different methods,
the Bonferroni technique and the summation of chi-square
statistics, were used to evaluate the overall statistical
significance of multiple comparisons (17). In the case of
functional measurements of Cl currents and of Cl/HCO3

exchange (Figs 2–4), analysis of variance was used. All
P-values were based on two-sided comparisons and P-values
of less than 0.05 were considered to indicate statistical
significance.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
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